WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol "SYRS," and will be led by Syros’ existing management team,... WebMar 2, 2024 · Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Dec 12, 2024 Syros Pharmaceuticals Announces Publication in Blood Advances …
TYME stock surges on merger agreement with Syros Pharmaceuticals …
WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ … WebApr 7, 2024 · Syros Pharmaceuticals is part of the Pharmaceuticals industry, and located in Massachusetts, United States. Syros Pharmaceuticals Location 35 Cambridge Park Dr, Cambridge, Massachusetts, 02140, United States Description Read More Industry Pharmaceuticals Healthcare Discover more about Syros Pharmaceuticals Beth Ann Work … bebes miniaturas
Syros Pharmaceuticals, Inc.
WebNov 14, 2024 · Closed Merger with TYME Technologies and Concurrent PIPE; Proceeds from Combined Transactions Augment Cash Balance, Ending Third Quarter with … WebJul 5, 2024 · Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement News Download as PDF July 05, 2024 Combined Company Will Operate as Syros Pharmaceuticals and Continue to Advance … WebApr 15, 2024 · Syros Pharmaceuticals, Inc engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by... divisor\u0027s jx